Front-line chemotherapy with docetaxel and gemcitabine administered every two weeks in patients with metastatic breast cancer: a multicenter phase II study (Q33363792)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Front-line chemotherapy with docetaxel and gemcitabine administered every two weeks in patients with metastatic breast cancer: a multicenter phase II study |
scientific article |
Statements
1 reference
Front-line chemotherapy with docetaxel and gemcitabine administered every two weeks in patients with metastatic breast cancer: a multicenter phase II study (English)
1 reference
D Mavroudis
1 reference
N Malamos
1 reference
A Polyzos
1 reference
Ch Kouroussis
1 reference
Ch Christophilakis
1 reference
I Varthalitis
1 reference
N Androulakis
1 reference
K Kalbakis
1 reference
G Milaki
1 reference
V Georgoulias
1 reference
Breast Cancer Study Group of the Hellenic Oncology Research Group (HORG)
1 reference
1 January 2004
1 reference
1 reference
67
1 reference
3-4
1 reference
250-256
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference